Sargent Bickham Lagudis’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$28.9K Hold
907
﹤0.01% 538
2022
Q3
$26K Hold
907
﹤0.01% 530
2022
Q2
$32K Hold
907
﹤0.01% 507
2022
Q1
$45K Hold
907
﹤0.01% 477
2021
Q4
$51K Hold
907
﹤0.01% 448
2021
Q3
$53K Hold
907
﹤0.01% 435
2021
Q2
$57K Hold
907
﹤0.01% 428
2021
Q1
$58K Hold
907
0.01% 417
2020
Q4
$47K Buy
+907
New +$44.7K ﹤0.01% 437
2018
Q4
Sell
-142
Closed -$5K 808
2018
Q3
$5K Buy
+142
New +$5.91K ﹤0.01% 694

Other funds holding XRAY

Sargent Bickham Lagudis's XRAY Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Dentsply Sirona (XRAY) position steady in Q4 2022 at 907 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Sargent Bickham Lagudis first reported a position in XRAY in Q3 2018 and has held it in 10 quarters since. The position peaked at $58K in Q1 2021. 436 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

  • Sargent Bickham Lagudis held 907 shares of Dentsply Sirona worth $28.9K as of Q4 2022.
  • Sargent Bickham Lagudis left its Dentsply Sirona share count unchanged in Q4 2022.
  • Dentsply Sirona made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #538 holding.
  • Sargent Bickham Lagudis first reported a position in Dentsply Sirona in Q3 2018 and has held it in 10 quarters since.
  • Sargent Bickham Lagudis's Dentsply Sirona position peaked at $58K in Q1 2021.
  • 436 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.